Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v5-EN
Language English English
Date Updated 2018-04-21 2018-04-21
Drug Identification Number 00807788 00807788
Brand name BLEPHAMIDE OPHT SUSPENSION BLEPHAMIDE OPHT SUSPENSION
Common or Proper name Sulfacetamide sodium Sulfacetamide sodium
Company Name ALLERGAN INC ALLERGAN INC
Ingredients PREDNISOLONE ACETATE SULFACETAMIDE SODIUM PREDNISOLONE ACETATE SULFACETAMIDE SODIUM
Strength(s) 0.2% 10% 0.2% 10%
Dosage form(s) DROPS DROPS
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 5mL 5mL
ATC code S01CA S01CA
ATC description ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2018-02-15 2018-02-15
Actual start date 2018-02-15 2018-02-15
Estimated end date 2018-03-16 2018-03-16
Actual end date 2018-04-20 2018-04-20
Shortage status Resolved Resolved
Company comments Global Production Delay Global Production Delay
Health Canada comments